Coloplast (Buy, TP: DKK590.00) - Growth likely to accelerate in 2019
At the time of its strategy update in November Coloplast said it had decided to increase investments with the aim of growing organically at the higher end of its 7–9% long-term target, with the main question for investors being when this will materialise. We still view Coloplast’s history of outgrowing the market a result of its superior product innovation, a trend we expect to accelerate in 2019 on product launches such as SenSura Mio Concave. We see a particularly good buying opportunity and have lifted our target price to DKK590 (570).
DNB Markets is the investment banking arm of DNB Bank ASA and is focused primarily on the Nordic region, as well as internationally on niches such as global shipping, energy and related services, and seafood. DNB Markets offers services in FICC, Equities and Investment Banking advisory from offices in Oslo, Stockholm, London, Singapore and New York. Equity research coverage is offered on c250 Nordic companies. DNB was ranked no.2 in Extel Nordic Research 2017. The DNB Markets’ Credit and FICC Macro & FX Research teams are repeatedly highly rated by Prospera Nordic Institutional Investor Surveys.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.